独立的二次剂量计算用于患者特异性质量保证:蒙特卡洛和定制光束建模的定量效益
Lone Hoffmann1,2, Mai-Britt Linaa1, Ditte Sloth Møller1,2
1Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Journal of applied clinical medical physics
|September 24, 2025
概括
与分析算法相比,蒙特卡洛模拟为独立的二次剂量计算 (ISDC) 提供了更高的准确性. 定制的光束模型进一步提高了这种准确性,允许在放射治疗中采用更严格的质量保证标准.
科学领域:
- 医学物理 医学物理
- 辐射瘤学 辐射瘤学
- 计算剂量计计算剂量计.
背景情况:
- 独立的二次剂量计算 (ISDC) 对于辐射治疗中患者特定的质量保证至关重要.
- 蒙特卡洛 (MC) 系统正在成为ISDC传统分析算法更准确的替代方案.
研究的目的:
- 将MC系统的准确性和临床相关性与ISDC分析算法进行比较.
- 评估定制与通用光束模型对MC系统性能的影响.
- 以临床相关参数,行动水平和工作负载来量化好处.
主要方法:
- 分析了来自20个病例类的100个患者计划,最初计划使用Acuros XB.
- 使用Mobius3D (M3D) 和SciMoCa (SMC) 进行剂量计算,使用定制 (SMCcbm) 和通用 (SMCgen) 束模型.
- 在不同质量保证失败率下,确定了玛通量 (Gamma Pass Rate, GPR) 和平均目标剂量差 (Raddy Dose Difference, RADD) 的行动水平.
主要成果:
- 与M3D相比,MC系统,特别是自定义光束模型 (SMCcbm) 实现了显著更严格的操作水平 (例如,GPR<95%在2%/1mm, D >1%).
- 结合使用GPR和DD的标准,整体质量保证工作量减少到不到5%.
- SMC中的故障与患者密度模型有关,而M3D的故障与异质性处理有关;SMC中的性能差异归因于通用光束模型.
结论:
- 蒙特卡洛模拟促进了更严格的接受标准,并可以识别处理计划系统 (TPS) 调试错误.
- 在将其应用于独立二次剂量计算 (ISDC) 之前,对通用光束模型的彻底验证至关重要.
更多相关视频
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
3.1K
10:33Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
Published on: September 4, 2017
16.5K
相关概念视频
Dose Size and Dosing Frequency: Determination Methods
278
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
278
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
222
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
222
